PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,687,000 | +128.0% | 70,000 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $740,000 | +134.9% | 70,000 | 0.0% | 0.00% | – |
| Q3 2022 | $315,000 | +12.5% | 70,000 | 0.0% | 0.00% | – |
| Q2 2022 | $280,000 | -45.3% | 70,000 | 0.0% | 0.00% | – |
| Q1 2022 | $512,000 | +30.3% | 70,000 | 0.0% | 0.00% | – |
| Q4 2021 | $393,000 | -12.3% | 70,000 | 0.0% | 0.00% | – |
| Q3 2021 | $448,000 | -24.1% | 70,000 | 0.0% | 0.00% | – |
| Q2 2021 | $590,000 | -19.7% | 70,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $735,000 | -38.0% | 70,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,186,000 | +32.1% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $898,000 | -9.1% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $988,000 | +39.9% | 70,000 | -8.8% | 0.00% | +100.0% |
| Q1 2020 | $706,000 | -32.3% | 76,725 | +9.6% | 0.00% | 0.0% |
| Q4 2019 | $1,043,000 | +118.2% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $478,000 | -81.2% | 70,000 | -66.7% | 0.00% | 0.0% |
| Q2 2019 | $2,541,000 | – | 210,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,195,116 | $26,849,000 | 1.32% |
| DG Capital Management, LLC | 544,222 | $3,483,000 | 0.71% |
| ADVISORY RESEARCH INC | 237,500 | $1,520,000 | 0.10% |
| Ghost Tree Capital, LLC | 50,000 | $320,000 | 0.09% |
| Perceptive Advisors | 948,481 | $6,070,000 | 0.09% |
| Virtus ETF Advisers LLC | 23,667 | $151,000 | 0.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 241,411 | $1,545,000 | 0.06% |
| NinePointTwo Capital LLC | 21,077 | $134,000 | 0.05% |
| Newbridge Financial Services Group, Inc. | 13,000 | $83,000 | 0.05% |
| 683 Capital Management, LLC | 198,429 | $1,270,000 | 0.05% |